David L. Eigen is the Co-Founder and Co-Managing Partner (also listed as Managing Member) of P5 Health Ventures. See sector focus and contact routes.
David L. Eigen is the Co-Founder and Co-Managing Partner (also listed as Managing Member) of P5 Health Ventures, a healthcare-focused venture capital firm he started in 2015. His investment thesis centers on companies that fundamentally change healthcare delivery, specifically targeting digital health and advanced diagnostics while explicitly excluding drug development. Eigen invests in healthcare companies across the United States, with the firm headquartered in Fairfield, Connecticut, though he is also associated with Philadelphia, PA. While specific check sizes and lead/follow behavior are not publicly documented, he serves as a Board Observer for multiple portfolio companies including binah.ai, Clarapath, Inc., and Babyscripts. Notable named portfolio companies include Leviant, which he recently invested in, as well as binah.ai, Clarapath, FIGUR8, Inc., and Iterative Scopes. Eigen’s distinctive point of view is that he does not invest in pharmaceutical drugs, focusing instead on systemic improvements to healthcare delivery through technology.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Philadelphia.
Investors like David L. Eigen · Full investor directory · Investor access · Company funding database